NCT06935500

Brief Summary

This study aims to compare the efficacy, success rates, and stone-free rates of endoscopic ureteral stone treatment performed using two different sizes of ureteroscopes. Additionally, the psychological stress experienced by the surgeon will be evaluated immediately before and immediately after the procedure using the six-item short-form of the State Scale of the Spielberger State-Trait Anxiety Inventory (STAI). The findings will provide insight into the impact of ureteroscope size on procedural outcomes and surgeon stress levels, contributing to the optimization of ureteroscopic stone treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 3, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 20, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

July 10, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2025

Completed
5 months until next milestone

Results Posted

Study results publicly available

April 13, 2026

Completed
Last Updated

April 13, 2026

Status Verified

November 1, 2025

Enrollment Period

4 months

First QC Date

April 3, 2025

Results QC Date

March 3, 2026

Last Update Submit

March 25, 2026

Conditions

Keywords

ureteral stoneanxiety inventoryureteroscoppic lithotripsyureteroscop

Outcome Measures

Primary Outcomes (1)

  • Change in STAI-TX1 Score (Postoperative - Preoperative)

    The State-Trait Anxiety Inventory (STAI), Form TX-1, is a validated instrument used to assess situational (state) anxiety. The STAI-TX1 consists of 20 items scored on a 4-point Likert scale, with total scores ranging from 20 to 80. Higher scores indicate greater levels of anxiety. In this study, the STAI-TX1 was administered immediately before and immediately after each procedure. A change score (ΔSTAI-TX1) was calculated by subtracting the preoperative score from the postoperative score (postoperative minus preoperative). Positive values (ΔSTAI-TX1 \> 0) indicate an increase in anxiety, whereas values ≤ 0 indicate no increase or a decrease in anxiety.

    Immediately before and immediately after the procedure

Study Arms (2)

4,5/6,5f URS

Group operated with 4.5/6.5f ureteroscope

Procedure: endoscopic ureteric lithotripsy

8/9,8f URS

Group operated with 8/9.8f ureteroscope

Procedure: endoscopic ureteric lithotripsy

Interventions

2 different sizes of ureteroscopes, 4.5/6.5f and 8/9.8f, will be used in the study.

4,5/6,5f URS8/9,8f URS

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients between 18-75 years of age who applied to the urology outpatient clinic and were planned for elective endoscopic ureteral stone operation

You may qualify if:

  • Presence of ureteral calculi
  • Use of Ho:YAG laser in ureteric lithotripsy
  • Patient's acceptance to participate in the study

You may not qualify if:

  • Presence of active urinary tract infection
  • Emergency operation of the patient
  • Presence of bilateral ureteral calculi
  • Patient refusal to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aydın State Hospital

Aydin, Aydın, 09100, Turkey (Türkiye)

Location

Related Publications (4)

  • Jones KI, Amawi F, Bhalla A, Peacock O, Williams JP, Lund JN. Assessing surgeon stress when operating using heart rate variability and the State Trait Anxiety Inventory: will surgery be the death of us? Colorectal Dis. 2015 Apr;17(4):335-41. doi: 10.1111/codi.12844.

    PMID: 25406932BACKGROUND
  • Omar M, Dorrah M, Khalifa A, El Sherif E, Sayedahmed K, Ghazwani Y, Noureldin YA. Randomized comparison of 4.5/6 Fr versus 6/7.5 Fr ureteroscopes for laser lithotripsy of lower/middle ureteral calculi: towards optimization of efficacy and safety of semirigid ureteroscopy. World J Urol. 2022 Dec;40(12):3075-3081. doi: 10.1007/s00345-022-04173-2. Epub 2022 Oct 8.

    PMID: 36208314BACKGROUND
  • Uzun H, Akca N. Is the 4.5-F ureteroscope (Ultra-Thin) an alternative in the management of ureteric and renal pelvic stones? Arab J Urol. 2018 Jun 21;16(4):429-434. doi: 10.1016/j.aju.2018.04.006. eCollection 2018 Dec.

    PMID: 30534443BACKGROUND
  • Atis G, Arikan O, Gurbuz C, Yildirim A, Erol B, Pelit S, Ulus I, Caskurlu T. Comparison of different ureteroscope sizes in treating ureteral calculi in adult patients. Urology. 2013 Dec;82(6):1231-5. doi: 10.1016/j.urology.2013.07.021. Epub 2013 Sep 12.

    PMID: 24035032BACKGROUND

MeSH Terms

Conditions

Ureterolithiasis

Condition Hierarchy (Ancestors)

Ureteral DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisMale Urogenital Diseases

Limitations and Caveats

No interpretative statements are provided in this section. All results are presented in the corresponding outcome measure data tables.

Results Point of Contact

Title
Gökhan Şahin, MD
Organization
Aydın State Hospital , Aydın, Turkey

Study Officials

  • GÖKHAN ŞAHİN

    Aydin Adnan Menderes University

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 3, 2025

First Posted

April 20, 2025

Study Start

July 10, 2025

Primary Completion

November 15, 2025

Study Completion

November 15, 2025

Last Updated

April 13, 2026

Results First Posted

April 13, 2026

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

It is not planned to share individual participant data unless specifically requested by the journal in which the study will be published.

Locations